Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(11%)
Results Posted
71%(5 trials)

Phase Distribution

Ph phase_3
1
11%
Ph not_applicable
1
11%
Ph phase_4
4
44%
Ph early_phase_1
1
11%
Ph phase_1
2
22%

Phase Distribution

3

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
2(22.2%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
4(44.4%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(7)
Other(1)

Detailed Status

Completed7
Suspended1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (11.1%)
Phase 12 (22.2%)
Phase 31 (11.1%)
Phase 44 (44.4%)
N/A1 (11.1%)

Trials by Status

suspended111%
completed778%
recruiting111%

Recent Activity

1 active trials
Showing 5 of 9
recruitingphase_1

A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants

NCT07063342
completedearly_phase_1

Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls

NCT05880862
suspendednot_applicable

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

NCT03709992
completedphase_3

Anticholinergic vs. Botox Comparison Study

NCT01166438
completedphase_1

Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium

NCT02831231
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07063342Phase 1

A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult Participants

Recruiting
NCT05880862Early Phase 1

Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls

Completed
NCT03709992Not Applicable

Trospium Chloride vs Tamsulosin in Treatment of Ureteral Stent Related Symptoms:

Suspended
NCT01166438Phase 3

Anticholinergic vs. Botox Comparison Study

Completed
NCT02831231Phase 1

Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium

Completed
NCT01922115Phase 4

The Effect of Anticholinergics on Cognitive Function in the Elderly

Completed
NCT00863551Phase 4

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial

Completed
NCT01178827Phase 4

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial

Completed
NCT01089751Phase 4

Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9